Citius Pharmaceuticals Announces $3 Million Registered Direct Offering
11/15/2024 | Press release | Distributed by Public on 11/15/2024 12:33
Please select the service you want to use:
Smartlinks | JPMorgan Chase & Co. | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Issue of Shares and Capital Increase | Public Share Offering | Investment Funds | Banks | Borsa Italiana | London Stock Exchange (LSE) | New York Stock Exchange (NYSE) | Frankfurt Stock Exchange | Six Swiss Exchange | Sao Paulo Stock Exchange (B3) | Vienna Stock Exchange (ATX) | Berlin Stock Exchange | Dusseldorf Stock Exchange | Hamburg Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | Santiago Stock Exchange | Bolsa Mexicana de Valores (BMV) | Buenos Aires Stock Exchange (BCBA) | Lima Stock Exchange (BVL) | Colombia Securities Exchange | Kazakhstan Stock Exchange (KASE) | Bulgarian Stock Exchange | BX Swiss | Tradegate Exchange | XETRA | NYSE American | NYSE ARCA Equities | Bolsa Electrónica de Chile | Nasdaq Capital Market | Cboe Canada | Cboe BZX Exchange | Cboe BXE Europe | Cboe CXE Europe | Cboe Off Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | FINRA Alternative Display Facility (ADF) | Aquis Exchange | Investors Exchange (IEX) | Omega ATS | Lynx ATS | SIGMA X MTF | EuroTLX | Bolsa Institucional de Valores (BIVA) | Aquis Exchange Europe | Equiduct | Hannover Stock Exchange | Nasdaq BX | Nasdaq CX2 | Nasdaq CXC | Nasdaq Intermarket | Nasdaq PSX | NYSE Chicago | Turquoise
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact